|14 OCTOBER 2014|
Life Length, the world leader in telomere diagnostics and analysis, announced an agreement with the Freiburg Medical Laboratory Middle East (FML) in Dubai to offer the telomere test to its patients. FML is a joint venture of the University of Freiburg, Synlab Laboratories (Germany) and Al Abbas Group (UAE).
Stephen J. Matlin, CEO, Life Length said, “We are delighted to partner with FML which brings the highest international standards to lab services and diagnostics in the Middle East. The Life Length Telomere Analysis Technology® (TAT®) offers a unique biomarker since telomeres are best predictors of biological age that is closely related with the onset of cardiovascular diseases the incidence of which is relatively high in this region particularly in the UAE.”
PD Dr. med. Michaela Jaksch, General Manager and Medical Director, FML noted, “We are pleased to partner with Life Length. The telomere test has been shown to be an independent assessment for cardiovascular and age-related diseases. Our goal is to provide patients, doctors, clinics, polyclinics and hospitals with sophisticated state-of-the-art lab-analysis and routine medical tests of the highest standards.”
